Genetic Technologies Ltd (GTG) — Capital Reinvestment Ratio

Latest as of March 2022: 0.24x

Genetic Technologies Ltd (GTG) has a Capital Reinvestment Ratio of 0.24x as of March 2022, meaning it reinvests 0% of its operating cash flow (AU$337.45K) in capital expenditures (AU$79.79K). See Genetic Technologies Ltd net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

AU$337.45K
AUD

Capital Expenditures

AU$79.79K
AUD

Data as of

Mar 2022
Most recent filing

Genetic Technologies Ltd Capital Reinvestment Ratio (2007–2011)

This chart tracks Genetic Technologies Ltd's Capital Reinvestment Ratio across 3 annual periods. Check GTG cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Genetic Technologies Ltd (2007–2011)

Year-by-year Capital Reinvestment Ratio for Genetic Technologies Ltd from 2007 to 2011. For live market cap and broader valuation context, see GTG stock market capitalisation.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2011 0.06x AU$2.23 Million AU$139.68K ▼ -77.6%
2008 0.28x AU$423.68K AU$118.26K ▲ +286.6%
2007 0.07x AU$2.20 Million AU$158.87K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow